AlphaYouAT
Insider buying
Andrew T. Kaplan bought $134M of Kailera Therapeutics, Inc. (KLRA) stock
Andrew T. Kaplan, Dir, 10% of Kailera Therapeutics, Inc. (KLRA), bought 8,398,438 shares of KLRA stock worth $134M, per an SEC Form 4 filed Apr 20, 2026.
It was an open-market purchase.
The trade happened on Apr 16, 2026, 4 days before it was made public.
- Traded
- Apr 16, 2026
- Disclosed
- Apr 20, 2026
- Filing delay
- 4 days
- Role
- Dir, 10%
- Source
- SEC Form 4
More KLRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.